title: amlrrays 3310

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: 95d Troglitazone_3

status: Public on Apr 13 2004

type: RNA

city: Boston

first: Brig

last: Mecham

state: MA

address: 20 Shattuck St

country: USA

institute: Harvard Medical School

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 3

molecule: total RNA

organism: Homo sapiens

source_name: human primary trophoblast


title: amlrrays 2250

status: Public on Apr 15 2004

city: Houston

first: Roel

last: Verhaak

state: TX

address: 1400 Pressler St

department: Bioinformatics and Comp Bio

institute: MD Anderson Cancer Center

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=pos, cEBPa=neg

source_name: blasts and mononuclear cells


title: MCF7_U133_AMyb1

status: Public on Apr 16 2004

city: Albuquerque

first: Scott

middle: A.

last: Ness

state: NM

department: Internal Medicine

institute: U. of New Mexico HSC

description:
MCF7 cells were infected with adenovirus expressing Green Fluorescent protein and A-Myb. After 16 hours, RNA was extracted using a Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA. Initial data analysis was performed using Affymetrix MAS software.
Keywords = human, MCF7 cells, breast cancer, Myb oncogene

source_name: MCF7 breast cancer cells


title: 95d Troglitazone_5

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 5


title: 95d Troglitazone_2

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 2


title: 95d Control_5

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with DMSO as a vehicle control.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation. Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 1, replicate 5


title: 95d GW7845_2

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with 1 uM GW7845.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 3, replicate 2


title: 95d GW7845_3

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with 1 uM GW7845.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 3, replicate 3


title: 95d Troglitazone_1

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 1


title: 95c GW7845_4

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with 1 uM GW7845.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 3, replicate 4


title: amlrrays 2681

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: 95c GW7845_5

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with 1 uM GW7845.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 3, replicate 5


title: 95d Troglitazone_4

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 4


title: 95c GW7845_3


title: 95c GW7845_2


title: 95c GW7845_1

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with 1 uM GW7845.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 3, replicate 1


title: 95d Control_2

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with DMSO as a vehicle control.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation. Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 1, replicate 2


title: 95d Control_3

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with DMSO as a vehicle control.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation. Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 1, replicate 3


title: 95d Control_4

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with DMSO as a vehicle control.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation. Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 1, replicate 4


title: 95c Troglitazone_4


title: 95c Troglitazone_5


title: 95c Control_5


title: 95c Troglitazone_2


title: 95c Control_4


title: 95c Troglitazone_1


title: 95c Control_1

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This sample was treated with DMSO as a vehicle control.  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation. Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 1, replicate 1


title: 95b GW7845_2


title: 95b GW7845_4


title: 95e GW7845_3


title: 95e GW7845_5


title: 95e GW7845_4


title: 95b Troglitazone_5


title: 95b Troglitazone_2


title: 95b Troglitazone_4


title: 95c Control_3


title: 95c Control_2


title: 95c Troglitazone_3

description: Primary cultures of human trophoblasts were established from normal, term placenta.  Cells were treated five hours after plating.  This  sample was treated with 10 uM Troglitazone .  RNA was extracted after 48 hours of treatment using Tri-reagent. Each sample was pooled from three individual placentas prior to target generation.  Targets were produced using standard Affymetrix procedures from 30ug of total RNA.  This sample is also known as Treatment 2, replicate 3


title: 95b GW7845_3


title: 95b GW7845_1


title: 95b Control_4


title: 95e GW7845_2


title: 95e GW7845_1


title: 95b Control_5


title: 95b Troglitazone_1


title: 95b Control_2


title: 95b GW7845_5


title: 95b Control_3


title: 95e Troglitazone_4


title: 95e Troglitazone_5


title: 95d Control_1


title: 95e Troglitazone_3


title: 95e Troglitazone_1


title: 95e Troglitazone_2


title: 95b Control_1


title: 95e Control_5


title: 95e Control_3


title: Normal Breast Epithelium Control replicate 2 133A

description: Human mammary epithelial cells were purchased from Cambrex Bio Science and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.

source_name: Human Mammary Epithelial Cells


title: 95b Troglitazone_3


title: Normal Breast Epithelium Control replicate 1 133B


title: Breast Cancer cells HCC1954 replicate 1 133B

description: The HCC1954 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.

source_name: HCC1954 Breast Cancer cell line


title: Breast Cancer cells HCC1954 replicate 1 133A


title: 95e Control_4


title: Normal Breast Epithelium Control replicate 2 133B


title: 95e Control_2


title: HCC1954Cy3vsHMECCy5r1

description: The HCC1954 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.  Human mammary epithelial cells were purchased from Cambrex Bio Science and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.

source_name: MDA-MB436 Breast Cancer cell line


title: Breast Cancer cells HCC1954 replicate 2 133A


title: Breast Cancer cells MDA-MB-436 replicate 2 133A

description: The MDA-MB-436 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.


title: Breast Cancer cells HCC1954 replicate 2 133B


title: MDAMB436Cy3vsHMECCy5r1

description: The MDA-MB-436 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA. Human mammary epithelial cells were purchased from Cambrex Bio Science and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.


title: Breast Cancer cells MDA-MB-436 replicate 2 133B


title: MDAMB436Cy3vsHMECCy5r2

description: The MDA-MB-436 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA. Human mammary epithelial cells were purchased from Cambrex Bio Science and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA


title: HCC1954Cy3vsHMECCy5r2

description: The HCC1954 human breast cancer derived cell line was purchased from American Tissue Type Collection and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA.  Human mammary epithelial cells were purchased from Cambrex Bio Science and cultured according to the manufacturer's instructions. Cells were solubilized in TRIzol LS and RNA was extracted using the Quiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 7 ug of total RNA


title: 95e Control_1


title: Normal Breast Epithelium Control replicate 1 133A


title: mdx5cv TA sample 2

status: Public on Apr 12 2004

first: Judith

last: Haslett

description: Pooled TA RNA samples from five 8 wk old male mdx5cv mice

organism: Mus musculus

source_name: 8 wk old male mdx5cv TA


title: Breast Cancer cells MDA-MB-436 replicate 1 133A


title: mdx5cv TA sample 1


title: C57BL10 TA sample 2

description: Pooled TA RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 TA


title: mdx TA sample 1

description: Pooled TA RNA samples from five 8 wk old male mdx mice

source_name: 8 wk old male mdx TA


title: Breast Cancer cells MDA-MB-436 replicate 1 133B


title: mdx TA sample 2


title: C57BL10 TA sample 1


title: mdx5cv soleus sample 2

description: Pooled soleus RNA samples from five 8 wk old male mdx5cv mice

source_name: 8 wk old male mdx5cv soleus


title: mdx5cv quadriceps sample 1

description: Pooled quad RNA samples from five 8 wk old male mdx5cv mice

source_name: 8 wk old male mdx5cv quad


title: mdx quadriceps sample 1

description: Pooled quad RNA samples from five 8 wk old male mdx mice

source_name: 8 wk old male mdx quad


title: mdx5cv gastroc sample 1

description: Pooled gastroc RNA samples from five 8 wk old male mdx5cv mice

source_name: 8 wk old male mdx5cv gastroc


title: C57BL10 soleus sample 2

description: Pooled soleus RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 soleus


title: C57BL10 quadriceps sample 2

description: Pooled quad RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 quad


title: mdx5cv gastroc sample 2


title: mdx5cv soleus sample 1


title: mdx gastroc sample 2

description: Pooled gastroc RNA samples from five 8 wk old male mdx mice

source_name: 8 wk old male mdx gastroc


title: mdx quadriceps sample 2


title: mdx soleus sample 2

description: Pooled soleus RNA samples from five 8 wk old male mdx mice

source_name: 8 wk old male mdx soleus


title: C57BL10 quadriceps sample 1


title: C57BL10 gastroc sample 1

description: Pooled gastroc RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 gastroc


title: mdx gastroc sample 1


title: C57BL10 EDL sample 2

description: Pooled EDL RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 EDL


title: mdx5cv quadriceps sample 2


title: mdx5cv EDL sample 1

description: Pooled EDL RNA samples from five 8 wk old male mdx5cv mice

source_name: 8 wk old male mdx5cv EDL


title: C57BL10 soleus sample 1


title: mdx EDL sample 2

description: Pooled EDL RNA samples from five 8 wk old male mdx mice

source_name: 8 wk old male mdx EDL


title: mdx EDL sample 1


title: mdx soleus sample 1


title: C57BL10 gastroc sample 2


title: mdx diaphragm sample 1

description: Pooled diaphragm RNA samples from five 8 wk old male mdx mice

source_name: 8wk old male mdx diaphragm


title: mdx5cv diaphragm sample 2

description: Pooled diaphragm RNA samples from five 8 wk old male mdx5cv mice

source_name: 8 wk old male mdx5cv diaphragm


title: mdx diaphragm sample 2

source_name: 8 wk old male mdx diaphragm


title: mdx5cv EDL sample 2


title: C57BL10 EDL sample 1

source_name: 8 wk old male C57BL10


title: C57BL10 diaphragm sample 2

description: Pooled diaphragm RNA samples from five 8 wk old male C57BL10 mice

source_name: 8 wk old male C57BL10 diaphragm


title: U2-OS-ERa E2 4 hrs 1

status: Public on Apr 10 2004

city: Urbana

first: Fabio

last: Stossi

state: IL

address: 285 Burrill Hall, 407 S Goodwin

department: Molecular and Integrative Physiology

institute: University of Illinois at Urbana-Champaign

description: U2-OS human osteosarcoma cells were stably transfected with low levels of ERa. This sample represents E2 10nM treated cells for 4 hours.


title: U2-OS-ERa E2 24 hrs 1

description: U2-OS human osteosarcoma cells were stably transfected with low levels of ERa. This sample represents E2 10nM treated cells for 24 hours.


title: U2-OS-ERa vehicle control 2

description: U2-OS human osteosarcoma cells were stably transfected with low levels of ERa. This sample represents EtOH treated cells and was used as a control for the time-course experiment


title: U2-OS-ERa E2 4 hrs 2


title: U2-OS-ERa E2 48 hrs 1

description: U2-OS human osteosarcoma cells were stably transfected with low levels of ERa. This sample represents E2 10nM treated cells for 48 hours.


title: U2-OS-ERa E2 24 hrs 2


title: U2-OS-ERa E2 8 hrs 1

description: U2-OS human osteosarcoma cells were stably transfected with low levels of ERa. This sample represents E2 10nM treated cells for 8 hours.


title: U2-OS-ERa 8 hrs 2


title: U2-OS-ERa vehicle control 1

description: U2-OS human osteosarcoma cells were stably transfected with ERa at low levels. This sample represents EtOH treated cells and was used as a control for the time-course experiment


title: HSP27 3A vs WT 7-1 3a3

status: Public on Apr 09 2004

city: Reno

first: Kimberly

last: Baker

state: NV

address: 1664 North Virginia St.

department: Cell and Molecular Biology

institute: University of Nevada School of Medicine

description: human bronchial smooth muscle cells were infected with either an adenoviral construct containing a phosphorylation-mutant form of HSP27 (HSP27-3A) or the wild type form (HSP27-WT) for 4 days at 40 MOI, and stimulated with 10ng/mL IL-1beta, TNF-alfa, and gamma-IFN for 20 hours prior to harvest.

source_name: human bronchial smooth muscle cells


title: HSP27 3A vs WT 7-1 wt3


title: HSP27 3A vs WT 3-29 wt3(1)


title: HSP27 3A vs WT 3-29 3a3(2)


title: HSP27 3A vs WT 1-9 wt5


title: Ad vs Mock df cy3=mock

description: Human bronchial smooth muscle cells were growth arrested. The test was infected with empty adenoviral type 5 vector for 4 days at 40 MOI, while the control sample was mock infected (no virus).  Both were stimulated with 10 ng/mL IL-1beta, TNF-alfa, and gamma-IFN for 20 hours prior to harvest.


title: Cytokine Stimulated vs Unstimulated 5-9 +3

description: Both sets of cells were growth arrested, and one set was stimulated for 20 hours with 10 ng/mL IL-1beta, TNF-alfa, and gamma IFN.


title: HSP27 3A vs WT 1-9 wt3


title: HSP27 3A vs WT 3-29 wt3(2)


title: Cytokine Stimulated vs Unstimulated 5-9 +5


title: Cytokine Stimulated vs Unstimulated 12-6 +3


title: Ad vs Mock df cy3=ad


title: HSP27 3A vs WT 3-29 3a3(1)


title: Ad vs Mock s cy=ad


title: U2-OS-ERa E2 48 hrs 2


title: Cytokine Stimulated vs Unstimulaed 2-22 +3


title: Cytokine Stimulated vs Unstimulated 12-6 +5


title: Cytokine Stimulated vs Unstimulated 2-22 +5


title: Cytokine Stimulation vs Unstimulated 11-7 +3


title: 02-06Zc uterine myometrium frozen samples

city: Santa Clara

first: Chunmei

last: Liu

state: CA

address: 3380 Central Expressway

institute: Affymetrix

description: 02-06  uterine myometrium frozen samples

source_name: 02-06  uterine myometrium frozen samples


title: Cytokine vs Unstimulated 11-7 +5


title: mdx5cv diaphragm sample 1


title: 02-06D3c  uterine myometrium 72hr RNAlater stored samples

description: 02-06  uterine myometrium 72hr RNAlater stored samples


title: 02-06D1c  uterine myometrium 24hr RNAlater stored samples

description: 02-06  uterine myometrium 24hr RNAlater stored samples


title: 02-06 Fb uterine myometrium fresh samples

description: 02-06  uterine myometrium fresh samples

source_name: 02-06  uterine myometrium fresh samples


title: 02-06 Fc uterine myometrium fresh samples

description: 02-06  uterine myometrium fresh samples


title: 02-06Zb  uterine myometrium frozen samples


title: 02-02Za  uterine myometrium frozen stored samples

description: 02-02  uterine myometrium frozen stored samples


title: uterine myometrium 02-03 frozen samples

description: uterine myometrium 02-03  frozen

source_name: uterine myometrium 02-03 frozen samples


title: uterine myometrium 02-03D1a 24hrs RNAlater

description: uterine myometrium 02-03 24hrs RNAlater


title: CEA_SGF:ACI021

city: Evry

first: Thierry

last: Kortulewski

address: 2 rue Gaston Cremieux

country: France

institute: CEA/DRR/SGF/LGRH

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 2 days after drug withdrawal, labeled in Cy5 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy3.

source_name: total bone marrow cells from 5 transgenic mice at day 2 following drug withdrawal were extracted.

source_name: Total bone marrow cells from 8 mice (tibias and femoral cavity)


title: uterine myometrium 02-02Fc fresh prepared samples

description: uterine myometrium 02-02  fresh prepared samples


title: uterine myometrium 02-02 D3a 72hrs RNAlater

description: uterine myometrium 02-02  72hrs RNAlater


title: CEA_SGF:ACQ013

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 3 days after drug withdrawal, labeled in Cy3 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy5.

source_name: total bone marrow cells from 5 transgenic mice at day 3 following drug withdrawal were extracted.


title: 02-06D3a  uterine myometrium 72hr RNAlater stored samples

source_name: 02-06  uterine myometrium 72hr RNAlater stored samples


title: 02-02Zb  uterine myometrium frozen stored samples

source_name: 02-02  uterine myometrium frozen stored samples


title: CEA_SGF:ACI036


title: CEA_SGF:ACQ012

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 2 days after drug withdrawal, labeled in Cy3 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy5.


title: uterine myometrium 02-02Fa  fresh prepared samples


title: 02-06D1b  uterine myometrium 24hr RNAlater stored samples

source_name: 02-06  uterine myometrium 24hr RNAlater stored samples


title: uterine myometrium 02-02 24hr RNAlater

description: uterine myometrium 02-02  24hrs RNAlater

source_name: uterine myometrium 02-02 24hr RNAlater


title: CEA_SGF:ACQ010

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 3 days after drug withdrawal, labeled in Cy5 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy3.


title: CEA_SGF:ACQ007

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 1 day after drug withdrawal, labeled in Cy5 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy3.

source_name: total bone marrow cells from 5 transgenic mice at day 1 following drug withdrawal were extracted.


title: CEA_SGF:ACI022


title: CEA_SGF:ACQ009


title: CEA_SGF:ACI023


title: CEA_SGF:ACQ011

description: RNA sample from total bone marrow of transgenic mice injected during 1 week with ganciclovir was prepared 1 day after drug withdrawal, labeled in Cy3 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy5.


title: uterine myometrium 02-03 D3a 72hrs RNAlater

description: uterine myometrium 02-03 72hrs RNALater


title: CEA_SGF:ACR004

description: RNA sample from total bone marrow of wild type mice injected during 1 week with ganciclovir was labeled in Cy3 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy5.

source_name: total bone marrow cells from 7 wild type C57/Bl6 mice treated during 1 week with Ganciclovir.


title: CEA_SGF:ACR003

description: RNA sample from total bone marrow of wild type mice injected during 1 week with ganciclovir was labeled in Cy5 and hybridized against RNA sample from total bone marrow of wild type mice labeled in Cy3.


title: uterine myometrium 02-02 D1a 24hrs RNAlater

description: uterine myometrium 02-02 24hrs RNALater


title: uterine myometrium 02-03D3c 72hrs RNAlater

description: uterine myometrium 02-03 72hrs RNALater


title: CEA_SGF:ACI019


title: uterine myometrium 02-03 frozen

description: uterine myometrium 02-03 frozen stored sample

source_name: uterine myometrium 02-03 frozen


title: pbmc 5A

status: Public on Apr 07 2004

city: Orange

first: Peter

last: Connolly

institute: University of California, Irvine

description:
PBMCs were separated from whole blood of prior to onset of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as PRE 5A.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs

source_name: pbmcs


title: pbmc 3C

description:
PBMCs were separated from whole blood immediately following 1 hour of recovery from exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as RECOVERY 3C.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: C57BL10 diaphragm sample 1

description: Pooled diaphragm RNA samples from five 8 wk old male C57BL10 mice


title: pbmc 4C

description:
PBMCs were separated from whole blood immediately following 1 hour of recovery from exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as RECOVERY 4C.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 5C

description:
PBMCs were separated from whole blood immediately following 1 hour of recovery from exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as RECOVERY 5C.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: CEA_SGF:ACI020


title: CEA_SGF:ACH035


title: pbmc 4A

description:
PBMCs were separated from whole blood of prior to onset of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as PRE 4A.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 3A

description:
PBMCs were separated from whole blood of prior to onset of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as PRE 3A.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: CEA_SGF:ACH034


title: pbmc 5B

description:
PBMCs were separated from whole blood immediately following the end of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as END-EX 5B.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 4B

description:
PBMCs were separated from whole blood immediately following the end of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as END-EX 4B.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 1B

description:
PBMCs were separated from whole blood immediately following the end of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as END-EX 1B.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: Untreated 0 hr ( replicate 2a )

status: Public on Apr 06 2004

city: Oklahoma City

first: Stewart

middle: Alan

last: Shields

state: OK

address: 825 NE 13th St

department: Arthritis/Immunology

institute: Oklahoma Medical Research Foundation

description:
normal human bronchial epithelial (NHBE), Untreated 0 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: Untreated 0 hr ( replicate 2a )


title: pbmc 2B

description:
PBMCs were separated from whole blood immediately following the end of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as END-EX 2B.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: uterine myometrium 02-03 D1b

description: uterine myometrium 02-03 24hrs RNALater

source_name: uterine myometrium


title: pbmc 3B

description:
PBMCs were separated from whole blood immediately following the end of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as END-EX 3B.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 1A

description:
PBMCs were separated from whole blood of prior to onset of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as PRE 1A.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: pbmc 2A

description:
PBMCs were separated from whole blood of prior to onset of exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as PRE 2A.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: S9 only 4 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), S9 only 4 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 4 hr ( replicate 2a )


title: S9 only 8 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), S9 only 8 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 8 hr ( replicate 2a )


title: S9 only 2 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), S9 only 2 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 2 hr ( replicate 1a )


title: pbmc 2C

description:
PBMCs were separated from whole blood immediately following 1 hour of recovery from exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as RECOVERY 2C.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: S9 only 12 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), S9 only 12 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 12 hr ( replicate 1a )


title: CSC B + S9 12 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 12 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 12 hr ( replicate 1a )


title: S9 only 8 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), S9 only 8 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 8 hr ( replicate 1a )


title: Untreated 0 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), Untreated 0 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: Untreated 0 hr ( replicate 1a )


title: CSC B + S9 8 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 8 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 8 hr ( replicate 1a )


title: S9 only 2 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), S9 only 2 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 2 hr ( replicate 2a )


title: S9 only 4 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), S9 only 4 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: S9 only 4 hr ( replicate 1a )


title: CSC B + S9 2 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 2 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 2 hr ( replicate 1a )


title: pbmc 1C

description:
PBMCs were separated from whole blood immediately following 1 hour of recovery from exercise.  RNA was extracted using a Quiagen RNeasy Midi columns. Targets were produced using standard Affymetrix procedures from about 10ug of total RNA.  In this samples, pbmcs from three young healthy males were analyzed.  This sample is also known as RECOVERY 1C.
Keywords = Homo sapiens, pbmcs, genomic profile of exercise induced changes in gene expression in pbmcs


title: NORMALvsTUBULARCARCINOMA(fixed_LCM_PCR-IVT)-1

city: Seoul

first: Inchul

last: Lee

address: 388-1 Poongnap-Dong, Songpa-Gu

department: Pathology

country: South Korea

institute: University of Ulsan College of Medicine

description: Formalin-fixed, LCM, PCR-IVT-amplified aRNA, Normal vs Tubular Carcinoma

source_name: Tubular Carcinoma (fixed-LCM-PCR-IVT aRNA)

source_name: Normal mucosa (fixed-LCM-PCR-IVT aRNA)


title: NORMALvsTUBULARCARCINOMA(fixed_LCM_PCR-IVT)-2

source_name: Tubular Carcioma (fixed-LCM-PCR-IVT aRNA)


title: CSC B + S9 4 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 4 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 4 hr ( replicate 2a )


title: CSC A + S9 12 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 12 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 12 hr ( replicate 1a )


title: CSC A + S9 8 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 8 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 8 hr ( replicate 2a )


title: NORMALvsTUBULARADENOMA(fixed_LCM_PCR-IVT)-2

description: Formalin-fixed, LCM, PCR-IVT-amplified aRNA, Normal vs Tubular Adenoma

source_name: Tubular Adenoma (fixed-LCM-PCR-IVT aRNA)


title: CSC A + S9 8 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 8 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 8 hr ( replicate 1a )


title: CSC B + S9 12 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 12 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 12 hr ( replicate 2a )


title: CSC B + S9 4 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 4 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 4 hr ( replicate 1a )


title: SNU484vsMKN45(Unfixed_Unamplified)

description:
unfixed, unamplified
SNU484vsMKN45

source_name: SNU484(Xenograft tumor : unfixed, unamplified)

source_name: MKN45(Xenograft tumor : unfixed, unamplified)


title: CSC A + S9 4 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 4 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 4 hr ( replicate 2a )


title: CSC A + S9 4 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 4 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 4 hr ( replicate 1a )


title: NORMALvsTUBULARADENOMA(fixed_LCM_PCR-IVT)-1

description: Formalin-fixed, LCM, PCR-IVT-amplified aRNA, Normal vs. TubularAdenoma


title: CSC B + S9 2 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 2 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 2 hr ( replicate 2a )


title: uterine myometrium 02-02 D3c 72hrs RNAlater

description: uterine myometrium 02-02  72hrs RNAlater

source_name: uterine myometrium 02-02  72hrs RNAlater


title: CSC A + S9 2 hr ( replicate 1a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 2 hr ( replicate 1a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 2 hr ( replicate 1a )


title: HeminTimecourse_48hB

status: Public on Apr 05 2004

city: Philadelphia

first: Sankar

last: Addya

state: PA

address: 233 South 10th Street

department: Kimmel Cancer Center

institute: Thomas Jefferson University Hospital

description:
K562 cells (duplicate cultures A & B) are treated with 50 micromolar hemin for 0, 6, 12, 24, 48, 72 hours followed by RNA extraction and gene expression profiling on Affymetrix human U133A arrays and analysis by MAS 5.0
Keywords = Erythroleukemia cells
Keywords = hemin
Keywords = erythroid

source_name: K562 Cells


title: HeminTimecourse_12hA


title: SNU484vsMKN45(Formalin-fixed_PCR-IVT-amplified)

description: Formalin-fixed_PCR-IVT-amplified aRNA, SNU484vsMKN45


title: HeminTimecourse_72hB


title: HeminTimecourse_72hA


title: HeminTimecourse_24hA


title: HeminTimecourse_12hB


title: HeminTimecourse_0hB


title: CSC B + S9 8 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC B + S9 8 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC B + S9 8 hr ( replicate 2a )


title: HeminTimecourse_6hB


title: HeminTimecourse_24hB


title: CSC A + S9 12 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 12 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 12 hr ( replicate 2a )


title: HeminTimecourse_0hA


title: CSC A + S9 2 hr ( replicate 2a )

description:
normal human bronchial epithelial (NHBE), CSC A + S9 2 hr ( replicate 2a )
Keywords = cigarette smoke, microarray, S9 toxicity, bronchial cell

source_name: CSC A + S9 2 hr ( replicate 2a )


title: rep4 Day 6 (12293751)

status: Public on Apr 01 2004

city: Raleigh

first: Debbie

middle: Ross

last: Craig

state: NC

address: 840 Main Campus Drive

department: Forestry

institute: North Carolina State University

description: rep4 Day 6 (12293751)

organism: Pinus contorta

source_name: rep4 Day 6


title: rep4 Day 33 (12317038)

description: rep4 Day 33 (12317038)

source_name: rep4 Day 33


title: rep4 Day 0 (12292829)

description: rep4 Day 0 (12292829)

source_name: rep4 Day 0


title: HeminTimecourse_48hA


title: rep4 Day 12 (12292752)

description: rep4 Day 12 (12292752)

source_name: rep4 Day 12


title: rep2 Day 6 (12293662)

description: rep2 Day 6 (12293662)

source_name: rep2 Day 6


title: rep3 Day 12 (12293659)

description: rep3 Day 12 (12293659)

source_name: rep3 Day 12


title: rep4 Day 3 (12282532)

description: rep4 Day 3 (12282532)

source_name: rep4 Day 3


title: rep3 Day 33 (12292752)

description: rep3 Day 33 (12292752)

source_name: rep3 Day 33


title: rep3 Day 0 (12293755)

description: rep3 Day 0 (12293755)

source_name: rep3 Day 0


title: 6 hours of high light: wild type vs. npq1 lor1 (Biological sample: 2/ Slide: 1)

status: Public on Apr 02 2004

city: Berkeley

first: Heidi

middle: Kristine

last: Ledford

address: 111 Koshland Hall

department: Plant and Microbial Biology

institute: University of California, Berkeley

description: Part of a time course following a low light to high light shift. One of four slides (two biological replicates, each with a dye switch) used for this time point. Strains used are wild type (CC-125) and npq1 lor1. Results in "VALUE" column are the log2 of Cy3/Cy5 ratios following normalization in SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html).

organism: Chlamydomonas reinhardtii

source_name: wild type (6 h of high light treatment)

source_name: npq1 lor1 (6 h of high light treatment)


title: 6 hours of high light: wild type vs. npq1 lor1 (Biological sample: 2/ Slide: 2)

description: Part of a time course following a low light to high light shift. One of four slides (two biological replicates, each with a dye switch) used for this time point. Strains used are wild type (CC-125) and npq1 lor1. Results in "VALUE" column are the log2 of Cy5/Cy3 ratios following normalization in SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html).


title: rep3 Day 6 (12292748)

description: rep3 Day 6 (12292748)

source_name: rep3 Day 6


title: rep2 Day 9 (12293660)

description: rep2 Day 9 (12293660)

source_name: rep2 Day 9


title: rep3 Day 9 (12317112)

description: rep3 Day 9 (12317112)

source_name: rep3 Day 9


title: rep2 Day 0 (12293658)

description: rep2 Day 0 (12293658)

source_name: rep2 Day 0


title: rep4 Day 9 (12282146)

description: rep4 Day 9 (12282146)

source_name: rep4 Day 9


title: rep2 Day 12 (12282146)

description: rep2 Day 12 (12282146)

source_name: rep2 Day 12


title: 1 hour of high light: wild type vs. npq1 lor1 (Biological sample:2, slide:1)

source_name: npq1 lor1 (1 h of high light treatment)

source_name: wild type (1 h of high light treatment)


title: 6 hours of high light: wild type vs. npq1 lor1 (Biological sample: 1/ Slide: 1)


title: 1 hour of high light: wild type vs. npq1 lor1 (Biological sample:1, Slide:2)


title: rep2 Day 33 (12292327)

description: rep2 Day 33 (12292327)

source_name: rep2 Day 33


title: rep2 Day 3 (12282385)

description: rep2 Day 3 (12282385)

source_name: rep2 Day 3


title: rep3 Day 3 (12292749)

description: rep3 Day 3 (12292749)

source_name: rep3 Day 3


title: 1 hour of high light: wild type vs. npq1 lor1 (Biological sample: 2, Slide: 2)


title: 6 hours of high light: wild type vs. npq1 lor1 (Biological sample: 1/ Slide: 2)

source_name: npq1 lor1 (6 h of high-light treatment)

source_name: wild type (6 h of high-light treatment)


title: HeminTimecourse_6hA

source_name: K562 Cells


title: 1 hour of high light: wild type vs. npq1 lor1 (Biological sample: 1, slide: 1)

description:
Part of a time course following a low light to high light shift. One of four slides (two biological replicates, each with a dye switch) used for this time point. Strains used are wild type (CC-125) and npq1 lor1.
Result in "VALUE" column are the log2 of Cy3/Cy5 ratios following normalization in SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html).


title: rep1 Day 3 Day 6 (12293752)

description: rep1 Day 3 Day 6 (12293752)

source_name: rep1 Day 3 (Cy3)

source_name: rep1 Day 6 (Cy5)


title: rep1 Day 0 Day 33 (12316380)

description: rep1 Day 0 Day 33 (12316380)

source_name: rep1 Day 0 (Cy3)

source_name: rep1 Day 33 (Cy5)


title: rep1 Day 12 Day 9 (12292827)

description: rep1 Day 12 Day 9 (12292827)

source_name: rep1 Day 12 (Cy3)

source_name: rep1 Day 9 (Cy5)


title: rep1 Day 9 Day 6 (12282389)

description: rep1 Day 9 Day 6 (12282389)

source_name: rep1 Day 9 (Cy3)


title: rep1 Day 6 Day 9 (12317111)

description: rep1 Day 6 Day 9 (12317111)

source_name: rep1 Day 6 (Cy3)


title: rep1 Day 6 Day 3 (12292326)

description: rep1 Day 6 Day 3 (12292326)

source_name: rep1 Day 3 (Cy5)


title: rep1 Day 33 Day 0 (12317038)

description: rep1 Day 33 Day 0 (12317038)

source_name: rep1 Day 33 (Cy3)

source_name: rep1 Day 0 (Cy5)


title: rep1 Day 12 Day 33 (12293661)

description: rep1 Day 12 Day 33 (12293661)


title: EOM postnatal day 45 rep 3

city: Cleveland

first: Henry

middle: J.

last: Kaminski

state: OH

address: 11100 Euclid Avenue

department: Neurology

institute: Case Western Reserve University

description:
Affymetrix standard protocol run on rat RG-U34A array.
Keywords = extraocular muscle
Keywords = postnatal development
Keywords = microarray

organism: Rattus norvegicus

source_name: extraocular muscle


title: rep1 Day 9 Day 12 (12292826)

description: rep1 Day 9 Day 12 (12292826)

source_name: rep1 Day 12 (Cy5)


title: EOM postnatal day 28 rep 3


title: EOM postnatal day 45 rep 2


title: EOM postnatal day 45 rep 1


title: EOM-MEDIAL RECTUS

first: Sangeeta

last: Khanna

description:
Standard affymetrix protocol using human U133 array
Keywords = extraocular muscle
Keywords = microarray

organism: Macaca mulatta

source_name: Adult monkey whole medial rectus


title: rep1 Day 0 Day 3 (12282387)

description: rep1 Day 0 Day 3 (12282387)


title: EOM-lateral rectus

source_name: Adult monkey whole lateral rectus muscle


title: EOM postnatal day 28 rep 2


title: EOM-medial rectus 2


title: EOM Lateral rectus

source_name: Adult monkey whole lateral rectus


title: EOM postnatal day 21 rep 2


title: EOM postnatal day 21 rep 1


title: EOM postnatal day 21 rep 3


title: EOM layer-orbital1

description:
T7 based amplification of mRNA followed by the affymetrix standard protocol and run on human U133 (A & B) array sets
Keywords = extraocular muscle
Keywords = microarray

source_name: Adult monkey extraocular muscle global layer microdissected


title: EOM layer-global2

source_name: Adult monkey extraocular muscle global layer


title: EOM layer-orbital2

source_name: adult monkey extraocular muscle orbital layer


title: EOM layer-global1

source_name: Adult monkey extraocular muscle global layer microdissected using laser


title: EOM postnatal day 14 rep 3


title: EOM postnatal day 14 rep 1


title: EOM postnatal day 14 rep 2


title: rep1 Day 3 Day 0 (12282386)

description: rep1 Day 3 Day 0 (12282386)

source_name: rep1 Day 3 (Cy3)


title: EOM postnatal day 0 rep 2


title: Leg postnatal day 45 rep 2

source_name: gastrocnemius/soleus muscle


title: EOM postnatal day 0 rep 3


title: Leg postnatal day 45 rep 1


title: EOM postatal day 7 rep 2


title: EOM postnatal day 28 rep 1


title: EOM-lateral rectus2

description:
Standard affymetrix protocol on human U133 array
Keywords = extraocular muscle
Keywords = microarray


title: Leg postnatal day 45 rep 3


title: EOM-lateral rectus 1


title: EOM postnatal day 7 rep 3


title: Leg postnatal day 28 rep 3


title: EOM postnatal day 0 rep 1


title: Leg postnatal day 21 rep 3


title: EOM postnatal day 7 rep 1


title: Leg postnatal day 28 rep 1


title: Leg postnatal day 21 rep 2


title: EOM-medial rectus1

source_name: adult monkey whole medial rectus muscle


title: Leg postnatal day 28 rep 2


title: EOM medial rectus

source_name: Adult monkey whole medial rectus muscle


title: Leg postnatal day 21 rep 1


title: EOM layers-orbital 2

source_name: Adult monkey extraocular muscle orbital layer


title: WTK1 NO 12h:WTK1 U, rep 2

city: Bethesda

first: Ana

middle: I

last: Robles

state: MD

address: 37 Convent Dr 37/3060D

institute: National Cancer Institute/NIH

description:
mAdb experiment ID: 42341
WTK1 cells treated with 390 micromol nitric oxide and harvested 12 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v5.0p16-112502
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 12 hours

source_name: WTK1 NO 12h

source_name: WTK1 U


title: WTK1 NO 6h:TK6 U

description:
mAdb experiment ID: 42339
WTK1 cells treated with 390 micromol nitric oxide and harvested 6 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v5.0p16-112502
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 6 hours

source_name: WTK1 NO 6h


title: Leg postnatal day 14 rep 3


title: TK6 NO 24h:TK6 U, rep 5

description:
mAdb experiment ID: 34149
TK6 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v2.6p3-070202
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours

source_name: TK6 NO 24h

source_name: TK6 U


title: TK6 NO 12h:TK6 U, rep 2

description:
mAdb experiment ID: 42336
TK6 cells treated with 390 micromol nitric oxide and harvested 12 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v5.0p16-112502
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 12 hours

source_name: TK6 NO 12h


title: TK6 NO 6h:TK6 U

description:
mAdb experiment ID: 42334
TK6 cells treated with 390 micromol nitric oxide and harvested 6 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v5.0p16-112502
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 6 hours

source_name: TK6 NO 6h


title: EOM layers -orbital1


title: Leg postnatel day 14 rep 1


title: Leg postnatal day 14 rep 2


title: Leg postnatal day 7 rep 3


title: EOM Layers-global 2


title: EOM LAYER-GLOBAL1

source_name: Adult monkey extraocular muscle microdissected layers


title: A3-EGFP-negative

first: George

last: Cotsarelis

address: M8 Stellar Chance Laboratories, 422 Curie Blvd

department: Dermatology

institute: University of Pennsylvania School of Medicine

description: Mouse keratinocytes were isolated from K15-EGFP transgenic mice for FACS sorting. RNA sample from EGFP negative and alpha-6 integrin positive cells was used for Microarray analysis.

source_name: mouse skin


title: TK6 NO 24h:TK6 U, rep 2

description:
mAdb experiment ID: 33793
TK6 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours


title: A2-EGFP-negative


title: WTK1 NO 24h:WTK1 U, rep 2

description:
mAdb experiment ID: 33800
WTK1 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours

source_name: WTK1 NO 24h


title: TK6 NO 24h:TK6 U, rep 3

description:
mAdb experiment ID: 33794
TK6 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours


title: Leg postnatal day 7 rep 2


title: TK6 NO 24h:TK6 U, rep 4

description:
mAdb experiment ID: 34142
TK6 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v2.6p3-070202
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours


title: A2-EGFP-high

description: Mouse keratinocytes were isolated from K15-EGFP transgenic mice for FACS sorting. RNA sample from high EGFP and alpha-6 integrin positive cells was used for Microarray analysis.


title: Leg postatal day 7 rep 1


title: Leg postnatal day 0 rep 3


title: A3-EGFP-high


title: WTK1 Ar 24h:WTK1 U

description:
mAdb experiment ID: 32902
WTK1 cells treated with argon and harvested 24 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: argon
treatment_dose: vehicle
treatment_time: 24 hours

source_name: WTK1 Ar 24h


title: WTK1 NO 24h:WTK1 U, rep 3

description:
mAdb experiment ID: 33801
WTK1 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours


title: WTK1 NO 24h:WTK1 U, rep 1

description:
mAdb experiment ID: 32338
WTK1 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours

source_name: WTK1 24h NO


title: Leg postnatal day 0 rep 2

description:
Affymetrix standard protocol run on rat RG-U34A array.
Keywords = extraocular muscle
Keywords = postnatal development
Keywords = microarray


title: A1-EGFP-negative


title: TK6 Ar 24h:TK6 U

description:
mAdb experiment ID: 32901
TK6 cells treated with argon and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: argon
treatment_dose: vehicle
treatment_time: 24 hours

source_name: TK6 Ar 24h


title: TK6 NO 24h:TK6 U, rep 1

description:
mAdb experiment ID: 32336
TK6 cells treated with 390 micromol nitric oxide and harvested 24 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 24 hours

source_name: TK6 24h NO


title: Low light: wild type vs. npq1 lor1 (Biological sample: 2/ Slide: 1)

description: Part of a time course following a low light to high light shift. One of four slides (two biological replicates, each with a dye switch) used for this time point. Strains used are wild type (CC-125) and npq1 lor1. Results in "VALUE" column are the log2 of Cy3/Cy5 ratios following normalization in SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html).

source_name: wild type (grown in low light)

source_name: npq1 lor1 (grown in low light)


title: Low light: wild type vs. npq1 lor1 (Biological sample: 2/ Slide: 2)

description: Part of a time course following a low light to high light shift. One of four slides (two biological replicates, each with a dye switch) used for this time point. Strains used are wild type (CC-125) and npq1 lor1. Results in "VALUE" column are the log2 of Cy5/Cy3 ratios following normalization in SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html).


title: Leg postnatal day 0 rep 1

source_name: gastrocnemius/soleus muscle


title: Low light: wild type vs. npq1 lor1 (Biological sample: 1/ Slide: 2)


title: A1-EGFP-high


title: Low light: wild type vs. npq1 lor1 (Biological sample: 1/ Slide: 1)


title: WTK1 NO 12h:WTK1 U, rep 1

description:
mAdb experiment ID: 31350
WTK1 cells treated with 390 micromol nitric oxide and harvested 12 hours after the end of treatment versus untreated WTK1 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: WTK1
p53 allele: mutant M237I
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 12 hours

source_name: WTK1 NO 12h


title: 02B CF

status: Public on Mar 29 2004

city: Kansas City

first: Robert

middle: C

last: De Lisle

state: KS

address: 3901 Rainbow Blvd

department: Anatomy & Cell Biology

institute: Univ Kansas Med Ctr

description: Total RNA was prepared using TRIzol reagent from the pancreas one 56 day old male mouse.  The genotype was gastrin+/-, CFTR-/- on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.

source_name: Pancreas


title: 01B Con

description: Total RNA was prepared using TRIzol reagent from the pancreas one 56 day old male mouse.  The genotype was gastrin+/-, CFTR+/+ on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.


title: 02-P CF

description: Total RNA was prepared using TRIzol reagent from the pancreas one 58 day old male mouse.  The genotype was gastrin+/-, CFTR-/- on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.


title: Mouse Ovary 1 (technical replicate)

status: Public on Mar 28 2004

city: New Haven

first: Joel

last: Rozowsky

state: CT

address: 266 Whitney Ave, Bass 437

department: Molecular Biophysics & Biochemistry

institute: Yale University

description:
Triple selected polyA RNA for liver, kidney, ovary,
testis,  was obtained from Ambion (Austin, TX). Total
RNA was obtained form Ambion for hypothalamus samples.
All RNA samples had an agilent ratio greater
than 1 indicating that degradation had not occurred.
All  RNA samples were prepared from a pool of 10
different animals. The total RNA samples were
labeled for hybridization onto the microarray according
to affymetrix protocols listed at:
http://keck.med.yale.edu/affymetrix/protocols
Keywords = Sex Specific Transcription, Mouse, Affymetrix, Healthy Mammalian Tissue

source_name: Mouse Ovary


title: Mouse Testis 3

source_name: Mouse Testis


title: Mouse Testis 3 (technical replicate)


title: Mouse Testis 2 (technical replicate)


title: 01-P

description:
Total RNA was prepared using TRIzol reagent from the pancreas one 57 day old male mouse.  The genotype was gastrin+/-, CFTR+/+ on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.
Keywords = Cystic fibrosis
Keywords = pancreas


title: Mouse Ovary 2


title: TK6 NO 12h:TK6 U, rep 1

description:
mAdb experiment ID: 31562
TK6 cells treated with 390 micromol nitric oxide and harvested 12 hours after the end of treatment versus untreated TK6 cells.
Array Print: Hs-UniGEM2-v4.0p6-052402
cell_type: lymphoblastoid
cell_line: TK6
p53 allele: wild-type
treatment_agent: nitric oxide
treatment_dose: 390 micromol
treatment_time: 12 hours

source_name: TK6 U


title: Mouse Kidney Female 1

source_name: Mouse Kidney


title: Mouse Kidney Female 1 (technical replicate)


title: 02 CF

description: Total RNA was prepared using TRIzol reagent from the pancreas one 57 day old male mouse.  The genotype was gastrin+/-, CFTR-/- on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.


title: Mouse Testis 1 (technical replicate)


title: Mouse Testis 1


title: Mouse Kidney Female 3


title: Mouse Ovary 3 (technical replicate)


title: Mouse Kidney Male 2


title: Mouse Kidney Male 2 (technical replicate)


title: Mouse Kidney Female 2 (technical replicate)


title: Mouse Kidney Male 3


title: 01 Con

description: Total RNA was prepared using TRIzol reagent from the entire pancreas one 57 day old male mouse.  The genotype was gastrin+/-, CFTR+/+ on 95% black6, 5% 129Sv background.  Mice were fed Peptamen from age 10 days to prevent intestinal obstruction.


title: Mouse Kidney Female 2


title: Mouse Testis 2


title: Mouse Kidney Male 1


title: Mouse Kidney Male 1 (technical replicate)


title: Mouse Liver Female 2 (technical replicate)

source_name: Mouse Liver


title: Mouse Liver Female 1


title: Mouse Ovary 1


title: Mouse Liver Female 2


title: Mouse Ovary 3


title: Mouse Liver Male 2 (technical replicate)


title: Mouse Liver Male 3


title: Mouse Liver Female 3 (technical replicate)


title: Human Hypothalamus Female 5 (technical replicate)

description:
Post-mordem human hypothalamus total RNA samples were
obtained from Ambion (Austin, TX). All total RNA samples
has an agilent ratio greater than 1 indicating there
had been no degredation. The causes of death varied
as well as the age at death, but averaged aproximately
70 years of age. The total RNA samples were labeled
for hybridization onto the microarray according to
affymetrix protocols listed at:
http://keck.med.yale.edu/affymetrix/protocols
Keywords = Sex Specific Transcription, Human, Affymetrix, Healthy Mammalian Tissue

source_name: Human Hypothalamus


title: Mouse Liver Female 1 (technical replicate)


title: Human Hypothalamus Male 7


title: Human Hypothalamus Female 5


title: Mouse Kidney Male 3 (technical replicate)


title: Mouse Liver Male 1 (technical replicate)


title: Human Hypothalamus Female 3 (technical replicate)


title: Mouse Liver Male 2


title: Human Hypothalamus Male 6 (technical replicate)


title: Human Hypothalamus Female 3


title: Mouse Kidney Female 3 (technical replicate)


title: Human Hypothalamus Female 1


title: Human Hypothalamus Male 6


title: Human Hypothalamus Female 4 (technical replicate)


title: Human Hypothalamus Male 7 (technical replicate)


title: Human Hypothalamus Male 5 (technical replicate)


title: Mouse Liver Female 3


title: Mouse Liver Male 1


title: Human Hypothalamus Female 2 (technical replicate)


title: Mouse Hypothalamus Female 3 (technical replicate)

source_name: Mouse Hypothalamus


title: Human Hypothalamus Female 4


title: Mouse Hypothalamus Female 3


title: Human Hypothalamus Male 5


title: Mouse Hypothalamus Female 2 (technical replicate)


title: Mouse Liver Male 3 (technical replicate)


title: Mouse Ovary 2 (technical replicate)


title: Human Hypothalamus Female 2


title: Mouse Hypothalamus Female 2


title: Mouse Hypothalamus Male 3


title: Human Hypothalamus Male 4 (technical replicate)


title: Human Hypothalamus Male 4


title: Mouse Hypothalamus Male 2 (technical replicate)


title: Human Hypothalamus Male 3


title: Human Hypothalamus Male 3 (technical replicate)


title: Mouse Hypothalamus Female 1


title: Human Hypothalamus Male 2 (technical replicate)


title: Mouse Hypothalamus Male 3 (technical replicate)


title: Mouse Hypothalamus Male 1


title: Human Hypothalamus Male 2


title: Mouse Hypothalamus Male 2


title: Mouse Hypothalamus Female 1 (technical replicate)


title: GH treated Male-Male(cy5-cy3) #3-5K

status: Public on Mar 27 2004

city: Boston

first: David

last: Waxman

address: 5 Cummington Mall

department: Department of Biology and Bioinformatics Program

institute: Boston University

description:
The genetic expression profile for one male and one continuous GH treated male rat liver sample is given as a lowess normalized ratio (f=0.2).  This result is from a single random pairing of one of four males and one of four continuous GH treated males.  The purpose of this pairwise comparison is to highlight the GH-dependent differences in rat liver gene expression.
Keywords = Growth hormone
Keywords = liver sexual dimorphism
Keywords = cytochrome P450
Keywords = liver gene expression
Keywords = dual channel cDNA microarray

source_name: frozen adult male rat liver tissue prepared using Trizol


title: Human Hypothalamus Male 1


title: Human Hypothalamus Male 1 (technical replicate)


title: 20: FCHL patient #99-1225

first: Fulvio

last: Morello

address: 77 L. Pasteur Avenue

department: Medicine

institute: Brigham and Women's Hospital

description: RNA extracted from cultured lymphoblastic cell line obtained from FCHL (familial combined hyperlipemia) patient.

source_name: FCHL patient #99-1225


title: 21: NORMAL #99-0636

description: RNA extracted from cultured lymphoblastic cell line obtained from normal subject.


title: GH treated Male-Male(cy5-cy3) #4-5K


title: 18: FCHL patient #98-1479

source_name: FCHL patient #98-1479


title: 24: NORMAL #99-0739


title: GH treated Male-Male(cy3-cy5) #2-5K


title: 23: FCHL patient #99-0562

source_name: FCHL patient #99-0562


title: 16: NORMAL #99-1053


title: 19: NORMAL #99-0834


title: 17: NORMAL #99-0160


title: 22: NORMAL #99-0694


title: Female-Male (cy3-cy5) #3-5K

description:
The genetic expression profile for one male and one female rat liver sample is given as a lowess normalized ratio (f=0.2).  This result is from a single random pairing of one of four males and one of four females.  The purpose of this pairwise comparison is to highlight the sex-dependent differences in rat liver gene expression.
Keywords = Growth hormone
Keywords = liver sexual dimorphism
Keywords = cytochrome P450
Keywords = liver gene expression
Keywords = dual channel cDNA microarray

source_name: frozen adult female rat liver tissue prepared using Trizol


title: Female-Male(cy3-cy5) #4-5K


title: 15: NORMAL #99-0693


title: GH treated Male-Male(cy3-cy5) #1-5K


title: 14: FCHL patient #99-0712

source_name: FCHL patient #99-0712


title: 13: NORMAL #99-0583

description: RNA extracted from lymphoblastic cell line derived from normal subject.


title: 10: NORMAL #00-0386


title: Female-Male (cy3-cy5) #2-5K


title: GH Treated Male-Male(cy3-cy5) #4-RL

description:
The genetic expression profile for one male and one female continuous GH treated male liver sample is given as a lowess normalized ratio (f=0.2).  This result is from a single random pairing of one of four males and one of four GH treated males.  The purpose of this pairwise comparison is to highlight the GH-dependent differences in rat liver gene expression.
Keywords = Growth hormone
Keywords = liver sexual dimorphism
Keywords = cytochrome P450
Keywords = liver gene expression
Keywords = dual channel cDNA microarray


title: Female-Male(cy3-cy5) #4-RL


title: 11: FCHL patient #99-0308

description: RNA extracted from lymphoblastic cell line derived from FCHL (familial combined hyperlipemia) patient.

source_name: FCHL patient #99-0308


title: Female-Male(cy3-cy5) #3-RL


title: GH treated Male-Male(cy3-cy5) #1-RL

description:
The genetic expression profile for one male and one continuous GH treated rat liver sample is given as a lowess normalized ratio (f=0.2).  This result is from a single random pairing of one of four males and one of four continuous GH treated males.  The purpose of this pairwise comparison is to highlight the GH-dependent differences in rat liver gene expression.
Keywords = Growth hormone
Keywords = liver sexual dimorphism
Keywords = cytochrome P450
Keywords = liver gene expression
Keywords = dual channel cDNA microarray


title: GH treated Male-Male(cy3-cy5) #2-RL


title: 8: NORMAL #00-0074


title: IDMB 3

status: Public on Mar 25 2004

city: Madison

first: Paul

last: Hanlon

state: WI

institute: University of Wisconsin

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  Third replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF

source_name: C3H10T1/2 fibroblast


title: Female-Male(cy3-cy5) #2-RL


title: IDMB 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: Normal Rat Retina 3

status: Public on Mar 26 2004

city: Memphis

first: Eldon

middle: E

last: Geisert

state: TN

address: 855 Monroe Avenue

department: Ophthalmology

institute: University of Tennesse

description:
Normal Rat Rat retina from male Sprague-Dawley.  Retinas from two animas were pooled.
Lot batch = EEG094

source_name: Sprague-Dawley Rat retina (male)


title: IDMB 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 9: NORMAL #00-0504


title: 4: FCHL patient #98-1056

description: RNA extracted from cultured lymphoblastic cell line of FCHL patient

source_name: FCHL patient #98-1056


title: IDMB + EGF + TCDD 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after the addition of 10nM EGF.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: Normal Rat Retina 2

description:
Normal Rat Rat retina from male Sprague-Dawley.  Retinas from two animas were pooled.
Lot batch = EEG036


title: 1: FCHL #98-1176


title: IDMB + EGF 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after the addition of 10nM EGF.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: IDMB + EGF 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after the addition of 10nM EGF.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 2: FCHL patient #98-1103

source_name: FCHL patient #98-1103


title: Normal Rat Retina

description: Normal Rat Rat retina from male Sprague-Dawley.  Retinas from two animas were pooled.

source_name: Sprague-Dawley Rat (male)


title: 6: FCHL patient #98-1174

description: RNA extracted from cultured lymphoblastic cell line derived from FCHL (familial combined hyperlipemia) patient

source_name: FCHL patient #98-1174


title: IDMB + EGF + TCDD 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after the addition of 10nM EGF.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 7: NORMAL #00-0267

description: RNA extracted from cultured lymphoblastic cell line derived from normal subject


title: 3: FCHL patient #98-1405

source_name: FCHL patient #98-1405


title: Mouse Hypothalamus Male 1 (technical replicate)

description:
Triple selected polyA RNA for liver, kidney, ovary,
testis,  was obtained from Ambion (Austin, TX). Total
RNA was obtained form Ambion for hypothalamus samples.
All RNA samples had an agilent ratio greater
than 1 indicating that degradation had not occurred.
All  RNA samples were prepared from a pool of 10
different animals. The total RNA samples were
labeled for hybridization onto the microarray according
to affymetrix protocols listed at:
http://keck.med.yale.edu/affymetrix/protocols
Keywords = Sex Specific Transcription, Mouse, Affymetrix, Healthy Mammalian Tissue


title: 12: FCHL patient #99-1191

source_name: FCHL patient #99-1191


title: IDMB + TCDD 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: TCDD 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 5: FCHL patient #98-1281

source_name: FCHL patient #98-1281


title: UT 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: UT 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 12 days old rat spinal cord smpl 2

city: Stony Brook

first: Lorne

last: Mendell

state: NY

department: Neurobiology & Behavior

institute: Stony Brook University

description: expression of genes in L4-L6 spinal cord section from 12 days old rat. sampl 2

source_name: L4-L6 section of 12 days old rat spinal cord


title: TCDD 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: IDMB + TCDD 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after the initiation of adipogenesis using IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin).  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 2 days old rat spinal cord smpl 2

description: expression of genes in L4-L6 spinal cord section from 2 days old rat. sampl 2

source_name: L4-L6 section of 2 days old rat spinal cord


title: UT 3

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  Third replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: EGF+TCDD 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after addition of 10nM EGF.  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: EGF+TCDD 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  72 hours after addition of 10nM TCDD.  24 hours after addition of 10nM EGF.  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: 12 days old rat spinal cord smpl 1

description: expression of genes in L4-L6 spinal cord section from 12 days old rat. sampl 1


title: 2 days old rat spinal cord smpl 1

description: expression of genes in L4-L6 spinal cord section from 2 days old rat. sampl 1


title: EGF 2

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after addition of 10nM EGF.  Second replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: EGF 1

description:
72 hours after last serum addition, 24 hours after cells reached confluence.  24 hours after addition of 10nM EGF.  First replicate.  mRNA pooled from 6 individual cultures.
Keywords = Adipogenesis
Keywords = TCDD
Keywords = EGF


title: MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A

status: Public on Mar 24 2004

city: Urbana

first: Joshua

middle: David

last: Stender

institute: University of Illinois at Urbana-Champaign

description: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ 2Hr Treatment of 10 nM E2 Sample A

source_name: MDA-MB-231ER+ Breast Cancer Cells


title: MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B


title: PGA_IGF1R-dnPI3K_3191

city: Cambridge

first: Martina

last: Schinke

address: 7 Divinity Ave

department: Bauer Center for Genomic Research

institute: Harvard University

description:
IGF1 and IGF1 receptors (IGF1R) are present in the adult heart and have been shown to be essential for myocardial performance.  Insulin-like growth factor 1 (IGF1) is produced in numerous tissues particularly by the liver in response to growth hormone stimulation and is an important factor in the regulation of post-natal growth and development.  We have generated and characterized transgenic mice over-expressing the IGF1R. We crossed IGF1R transgenic mice with dominant negative (dn)PI3K (p110) and with constitutively active (ca)PI3K(p110) transgenic mice. Expression profiling was performed on the ventricles of IGF1R, IGF1R-caPI3K, IGF1R-dnPI3K, caPI3K, dnPI3K transgenic female mice at 3 months of age. Non-transgenic littermates were used as controls.
Keywords = insulin growth factor, IGF, cardiac, hypertrophy

source_name: Both Ventricles of the Heart


title: MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A

description: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A


title: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A


title: MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample B


title: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment of 10 nM E2 Sample B


title: Wild Type Control Set A

description: 231ER+ WT Control Sample Set A


title: MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ 2Hr Treatment of 10 nM E2 Sample B


title: PGA_IGF1R-dnPI3K_3190


title: PGA_IGF1R-caPI3K_1403


title: PGA_IGF1R-caPI3K_1401


title: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment of 10 nM E2 Sample B


title: dep2hr-6

status: Public on Mar 23 2004

city: Stanford

first: Peter

last: Brende

address: 279 Campus Dr

department: Developmental Biology

institute: Stanford University

description: LS3707 cells were grown in PYE + 0.3% xylose (PYEX) to an OD of 0.2 to 0.4, washed three times in PYE and resuspended in either PXEX, or PYE + 0.2% glucose (PYEG) in order to repress xylose promoter activity. Cultures were assayed after growth for 2 additional hours.

organism: Caulobacter vibrioides


title: control2hr-1

description: WT cells were grown in PYE + 0.3% xylose (PYEX) to an OD of 0.2 to 0.4, washed three times in PYE and resuspended in either PXEX, or PYE + 0.2% glucose (PYEG) in order to repress xylose promoter activity. Cultures were assayed after growth for 2 additional hours.


title: control2hr-4


title: control2hr-3


title: PGA_IGF1R_1400


title: control2hr-6


title: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A

department: Molecular and Integrative Physiology

description: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment of 10 nM E2 Sample A


title: PGA_IGF1R_1402


title: PGA_IGF1R-dnPI3K_1040


title: WT Control Sample B

description: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa Control Sample B


title: control2hr-2


title: control2hr-5


title: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A

description: MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment of 10 nM E2 Sample A


title: PGA_IGF1R-caPI3K_1057


title: dep2hr-5


title: Gene expression data from microdissected liver Control2

status: Public on Mar 22 2004

city: Vitry sur Seine

first: Cecile

last: Michel

address: 13, quai Jules Guesdes

department: Drug Safety Evaluation

institute: Aventis Pharma France

description:
Liver sections from F344 rats treated with Clofibric Acid (CA) (0, 0.29 or 0.54 %)
Keywords = Laser Capture Microdissection, Clofibric-Acid

source_name: microdissected liver sections from untreated rats


title: Gene expression data from from LCM-reference-time liver sections from 0.54% CA-treated rats


title: 267B1 vs. LNCaP. Array 4.

type: genomic

city: San Diego

first: Yipeng

last: Wang

institute: Vaccine Research Institute of San Diego

description: The methylation status of 267B1 and LNCaP are compared. DNA samples were digested with methylation sensitive enzyme HpaII, ligated with adaptor, PCR amplified and labeled with Cye Dye. The labeled target are hybridized with human promoter array. In general, methylated sequences will not be cut and will not be amplified. Only unmethylated sequences will be amplified and hybridized to arrays.

molecule: genomic DNA

source_name: prostate cell line 267B1 DNA, Cy3

source_name: prostate cell line LNCaP DNA, Cy5


title: 267B1 vs. PC3M. Array 3.

description: The methylation status of 267B1 and PC3M are compared. DNA samples were digested with methylation sensitive enzyme HpaII, ligated with adaptor, PCR amplified and labeled with Cye Dye. The labeled target are hybridized with human promoter array. In general, methylated sequences will not be cut and will not be amplified. Only unmethylated sequences will be amplified and hybridized to arrays.

source_name: prostate cell line PC3M DNA, Cy5


title: Gene expression data from microdissected liver Control


title: Gene expression data from LCM-reference-time liver Control

source_name: from LCM-reference-time liver sections from untreated rats


title: PGA_IGF1R_1055


title: Gene expression data from from LCM-reference-time liver sections from 0.29% CA-treated rats


title: dep2hr-3


title: dep2hr-7


title: Gene expression data from stained liver sections from 0.54% CA-treated rats3


title: Gene expression data from microdissected liver sections from 0.29% CA-treated rats


title: Gene expression data from microdissected liver sections from 0.54% CA-treated rats


title: Gene expression data from dehydrated liver sections from 0.54% CA-treated rats


title: 267B1 vs. PC3M. Array 4

source_name: prostate cell line 267B1 DNA, Cy5

source_name: prostate cell line PC3M DNA, Cy3


title: 267B1 vs. LNCaP. Array 3.

source_name: prostate cell line LNCaP DNA, Cy3


title: Gene expression data from stained liver sections from 0.54% CA-treated rats


title: dep2hr-2


title: Gene expression data from stained liver sections from 0.29% CA-treated rats7


title: Gene expression data from stained liver sections from 0.54% CA-treated rats4


title: Gene expression data from stained liver sections from 0.54% CA-treated rats2


title: Gene expression data from stained liver sections from 0.54% CA-treated rats5


title: Gene expression data from stained liver sections from 0.29% CA-treated rats6


title: Gene expression data from stained liver sections from 0.29% CA-treated rats3


title: Gene expression data from dehydrated liver Control

source_name: dehydrated liver sections from untreated rats


title: Gene expression data from stained liver sections from 0.29% CA-treated rats4


title: Gene expression data from stained liver sections from 0.29% CA-treated rats5


title: Gene expression data from dehydrated liver sections from 0.29% CA-treated rats


title: dep2hr-4


title: dep2hr-1


title: Gene expression data from stained liver Control7

source_name: stained liver sections from untreated rats


title: Gene expression data from stained liver Control2


title: Gene expression data from stained liver Control6


title: Gene expression data from stained liver Control8


title: Gene expression data from stained liver Control5


title: Gene expression data from stained liver Control


title: Gene expression data from stained liver Control3


title: Gene expression data from entire liver sections from 0.54% CA-treated rats5


title: Gene expression data from entire liver sections from 0.54% CA-treated rats4


title: Gene expression data from entire liver sections from 0.54% CA-treated rats3


title: Gene expression data from entire liver sections from 0.54% CA-treated rats6


title: Gene expression data from entire liver sections from 0.54% CA-treated rats2


title: Gene expression data from stained liver Control4


title: Gene expression data from entire liver sections from 0.54% CA-treated rats


title: Gene expression data from entire liver sections from 0.29% CA-treated rats8


title: Gene expression data from entire liver sections from 0.29% CA-treated rats5


title: Gene expression data from entire liver sections from 0.29% CA-treated rats2


title: Gene expression data from entire liver sections from 0.29% CA-treated rats4


title: Gene expression data from entire liver sections from 0.29% CA-treated rats6


title: Gene expression data from entire liver sections from 0.29% CA-treated rats7


title: Gene expression data from entire liver sections from 0.29% CA-treated rats


title: Gene expression data from entier liver Control8

source_name: entire liver sections from untreated rats


title: Gene expression data from stained liver sections from 0.29% CA-treated rats1


title: Gene expression data from entier liver Control7


title: Fol CS, Replicate 2

city: Rehovot

last: Fluhr

department: Plant Sciences

country: Israel

institute: Weizmann Institute of Science

description: Fol expression data. Carbon starvation, replicate 2.

organism: Fusarium oxysporum

source_name: Fol control

source_name: Fol carbon starvation


title: Fol NS, Replicate 3

description: Fol expression data. Nitrogen starvation, replicate 3.

source_name: Fol nitrogen starvation


title: Fol NS, Replicate 1

description: Fol expression data. Nitrogen starvation, replicate 1.


title: Fol NS, Replicate 2

description: Fol expression data. Nitrogen starvation, replicate 2.


title: Fol NS, Replicate 6

description: Fol expression data. Nitrogen starvation, replicate 6.


title: Fol NS, Replicate 5

description: Fol expression data. Nitrogen starvation, replicate 5.


title: Fol NS, Replicate 4

description: Fol expression data. Nitrogen starvation, replicate 4.


title: Gene expression data from entire liver sections from 0.29% CA-treated rats3


title: Gene expression data from entier liver Control4


title: Gene expression data from entier liver Control6


title: Fol CS, Replicate 1

description: Fol expression data. Carbon starvation, replicate 1.


title: Gene expression data from entier liver Control2


title: Gene expression data from entier liver Control5


title: Fol CS, Replicate 6

description: Fol expression data. Carbon starvation, replicate 6.


title: Fol CS, Replicate 5

description: Fol expression data. Carbon starvation, replicate 5.


title: Gene expression data from stained liver sections from 0.29% CA-treated rats2


title: Gene expression data from entier liver Control3


title: Fol CS, Replicate 3

description: Fol expression data. Carbon starvation, replicate 3.


title: Fol CS, Replicate 4

description: Fol expression data. Carbon starvation, replicate 4.


title: Gene expression data from entier liver Control


title: PC3M. mRNA expression. Array 1.

status: Public on Mar 21 2004

description: 10ug PC3M total RNA was used as template. The RNA amplification, labeling, hybridization and scanning were according to Affymetrix standard procedure. Affymetrix U133A chip was used.

source_name: prostate cancer cell line PC3M total RNA


title: 267B1 vs. LNCaP. Array 2.

source_name: prostate cell line 267b1 DNA, Cy3


title: 267B1. mRNA expression. Array 1.

description: 10ug 267B1 total RNA was used as template. The RNA amplification, labeling, hybridization and scanning were according to Affymetrix standard procedure. Affymetrix U133A chip was used.

source_name: prostate cell line 267B1 total RNA


title: 267B1 vs. PC3M. Array 2.


title: MGJZ030212027Asalivarygland

status: Public on Mar 19 2004

first: John

middle: R

last: Walker

address: 10675 John Jay Hopkins

institute: Genomics Institute of the Novartis Research Foundation

description: salivary gland


title: MGMH030228088Afertilizedegg

description: fertilized egg


title: MGMH030228088Bfertilizedegg

description: fertilized egg


title: MGMH030212037Bthyroid

description: thyroid


title: MGJZ030207135Btestis

description: testis


title: MGMH030402089Boocyte

description: oocyte


title: MGJZ030207135Atestis

description: testis


title: MGMH030228090Bblastocysts

description: blastocysts


title: 267B1 vs. PC3M. Array 1.


title: MGJZ030211016Bkidney

description: kidney


title: MGJZ030211018Bliver

description: liver


title: MGJZ030212027Bsalivarygland

description: salivary gland


title: MGMH030212060Apancreas

description: pancreas


title: MGMH030212051Bsmallintestine

description: small intestine; duodenum


title: MGMH030212067Amammarygland(lact)

description: mammary gland ; females with E18 embryos


title: MGMH030228089Aoocyte

description: oocyte


title: MGMH030228090Ablastocysts

description: blastocysts


title: 267B1 vs.LNCaP. Array 1.

description: The methylation status of 267B1 and LNCaP are compared. DNA samples were digested with methylation sensitive enzyme HpaII, ligated with adaptor, PCR amplified and labeled with Cye Dye. The labeled target are hybridized with human promoter array. In general, methylated sequences will not be cut and will not be amplified. Only unmethylated sequences will be amplified and hybridized to arrays.


title: MGJZ030211018Aliver

description: liver


title: MGMH030212067Bmammarygland(lact)


title: MGMH030212037Athyroid

description: thyroid


title: MGMH030212051Asmallintestine

description: small intestine; duodenum


title: MGMH030212060Bpancreas

description: pancreas


title: MGMH030312016Akidney

description: kidney


title: MGJZ030312066Bplacenta

description: placenta; females with E18 embryos


title: MGMH030312028Askeletalmuscle

description: skeletal muscle


title: MGJZ030312066Aplacenta

description: placenta; females with E18 embryos


title: MGJZ030207054Aheart

description: heart


title: MGMH030212061Bbrownfat

description: brown fat; interscapular depression


title: MGJZ030312082Acd8+Tcell


title: MGMH030212061Abrownfat

description: brown fat; interscapular depression


title: MGJZ030207054Bheart

description: heart


title: MGMH030312028Bskeletalmuscle

description: skeletal muscle


title: MGJZ030312081Acd4+Tcell


title: MGJZ030228033Bspleen

description: spleen


title: MGJZ030312081Bcd4+Tcell


title: MGMH030212052Astomach

description: stomach


title: MGMH030212052Bstomach

description: stomach


title: MGMH030311036Bthymus

description: thymus


title: MGMH030312056Abonemarrow

description: bone marrow; flushed from femur


title: MGJZ030228005Abone

description: bone; femur


title: MGMH030311036Athymus

description: thymus


title: MGMH030312056Bbonemarrow

description: bone marrow; flushed from femur


title: MGJZ030212069Bumbilicalcord

description: umbilical cord; E18 embryos


title: MGJZ030212069Aumbilicalcord

description: umbilical cord; E18 embryos


title: MGJZ030228017Blargeintestine

description: large intestine; cecum


title: MGJZ030312083Bb220+bcell


title: MGMH030211019Alung

description: lung


title: MGJZ030228017Alargeintestine

description: large intestine; cecum


title: MGJZ030228092Avomeralnasalorgan(VMO)

description: vomeral nasal organ


title: MGMH030211019Blung

description: lung


title: MGJZ030228005Bbone

description: bone; femur


title: MGJZ030228092Bvomeralnasalorgan(VMO)

description: vomeral nasal organ


title: MGJZ030312083Ab220+bcell


title: MGMH030311038Btongueepidermis

description: tongue epidermis; dorsal tongue surface


title: MGMH030311030Asnoutepidermis

description: snout epidermis; vibrissa epidermal region


title: MGJZ030312082Bcd8+Tcell


title: MGJZ030212025Bprostate

description: prostate


title: MGMH030311030Bsnoutepidermis


title: MGJZ030212055Bepidermis

description: epidermis; dorsal skin without fur


title: MGJZ030402093Amedialolfactoryepithelium(MOE)

description: main olfactory epithelium


title: MGMH030311010Adigits

description: digits


title: MGMH030228091Aembryoday10.5

description: embryo day 10.5


title: MGMH030228087Aembryoday9.5

description: embryo day 9.5


title: MGJZ030212025Aprostate

description: prostate


title: MGJZ030211002Aadrenalgland

description: adrenal gland


title: MGMH030401084Bembryoday6.5

description: embryo day 6.5


title: MGJZ030212055Aepidermis

description: epidermis; dorsal skin without fur


title: MGMH030228085Aembryoday7.5

description: embryo day 7.5


title: MGMH030311010Bdigits

description: digits


title: MGMH030228084Aembryoday6.5

description: embryo day 6.5


title: MGJZ030211004Abladder

description: bladder


title: MGMH030228087Bembryoday9.5

description: embryo day 9.5


title: MGMH030228086Aembryoday8.5

description: embryo day 8.5


title: MGMH030311038Atongueepidermis

description: tongue epidermis; dorsal tongue surface


title: MGMH030228091Bembryoday10.5

description: embryo day 10.5


title: MGJZ030211004Bbladder

description: bladder


title: MGJZ030211002Badrenalgland

description: adrenal gland


title: MGMH030228085Bembryoday7.5

description: embryo day 7.5


title: MGMH030228086Bembryoday8.5

description: embryo day 8.5


title: MGJZ030211001Badiposetissue

description: adipose tissue; mesenteric


title: MGJZ030211001Aadiposetissue

description: adipose tissue; mesenteric


title: MGJZ030228093Bmedialolfactoryepithelium(MOE)

description: main olfactory epithelium


title: MGJZ030228033Aspleen

description: spleen


title: MGMH030312023Aovary

description: ovary


title: MGMH030312023Bovary

description: ovary